Cargando…
The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
BACKGROUND: Age at presentation with primary biliary cholangitis (PBC) is associated with differential response to ursodeoxycholic acid (UDCA) therapy. Younger‐presenting patients are less likely to respond to treatment and more likely to need transplant or die from the disease. PBC has a complex im...
Autores principales: | Dyson, J. K, Wilkinson, N., Jopson, L., Mells, G., Bathgate, A., Heneghan, M. A., Neuberger, J., Hirschfield, G. M., Ducker, S. J., Sandford, R., Alexander, G., Stocken, D., Jones, D. E. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082554/ https://www.ncbi.nlm.nih.gov/pubmed/27640331 http://dx.doi.org/10.1111/apt.13794 |
Ejemplares similares
-
Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging
por: Grover, V. P. B., et al.
Publicado: (2016) -
Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: de Veer, Rozanne C., et al.
Publicado: (2022) -
Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease
por: Wang, W, et al.
Publicado: (2015) -
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
por: Jones, David E.J., et al.
Publicado: (2022) -
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study
por: Papastergiou, V, et al.
Publicado: (2013)